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response to depolarization by high extracellular KCl and that NO inhibits adenosine diphosphoribose (ADPR) cyclase, thereby reducing the Ca 2ϩ -induced Ca 2ϩ release. We isolated rat afferent arterioles, utilizing the magnetized microsphere method, and measured cytosolic Ca 2ϩ concentration ([Ca 2ϩ ]i) with fura-2, a preparation in which endothelial cells do not participate in [Ca 2ϩ ]i responses. KCl (50 mM)-induced depolarization causes an immediate increase in [Ca 2ϩ ]i of 151 nM. The blockers N -nitro-L-arginine methyl ester (of nitric oxide synthase), 1,2,4-oxodiazolo-[4,3-a]quinoxalin-1-one (ODQ, of guanylyl cyclase), KT-5823 (of PKG activation), and iberiotoxin (IBX, of BK Ca 2ϩ activity) do not alter the [Ca 2ϩ ]i response to KCl, suggesting no discernible endogenous NO production under basal conditions. The NO donor sodium nitroprusside (SNP) reduces the [Ca 2ϩ ]i response to 77 nM; IBX restores the response to control values. These data show that activation of BK Ca 2ϩ in the presence of NO/cGMP provides a brake on KCl-induced [Ca 2ϩ ]i responses. Experiments with the inhibitor of cyclic ADPR 8-bromo-cyclic ADPR (8-Br-cADPR) and SNP ϩ downstream inhibitors of PKG and BK Ca 2ϩ suggest that NO inhibits ADPR cyclase in intact arterioles. When we pretreat afferent arterioles with 8-bromoguanosine 3Ј,5Ј-cyclic monophosphate (8-Br-cGMP; 10 M), the response to KCl is 143 nM. However, in the presence of both IBX and 8-Br-cGMP, we observe a surprising doubling of the [Ca 2ϩ ]i response to KCl. In summary, we present evidence for effects of the NO/cGMP/PKG system to reduce [Ca 2ϩ ]i, via activation of BK Ca 2ϩ and possibly by inhibition of ADPR cyclase, and to increase [Ca 2ϩ ]i, by a mechanism(s) yet to be defined. potassium channel; renal microcirculation; adenine diphosphoribose cyclase; chloride channel FOR NEARLY 20 YEARS, investigators have explored mechanisms by which nitric oxide (NO) causes vasodilatation and blunts vasoconstriction. Nearly all studies of the renal microcirculation have examined renal blood flow (RBF) in intact animals or arteriolar diameter changes in isolated vessels or other in vitro preparations. To our knowledge, no laboratory has studied the Ca 2ϩ signaling events that occur as a consequence of exposure to NO or to the subsequent formation of cyclic GMP (cGMP) and activation of protein kinase G (PKG) in a renal resistance vessel.
The vasodilatory properties of the NO/cGMP/PKG system have been ascribed to stimulation or inhibition of numerous Ca 2ϩ signaling pathways in vascular smooth muscle cells (VSMC). Inhibition of inositol trisphosphate receptor (IP 3 R), the Na ϩ /Ca 2ϩ exchanger in both forward and reverse modes, voltage-gated L-type channels, adenosine diphosphoribose (ADPR) cyclase, phosphodiesterase 3 (responsible for cAMP degradation), canonical transient receptor potential (TRPC)6, and myosin light chain (MLC) phosphatase have been reported (13, 14, 21, 40, 42, 48) . NO/cGMP/PKG activates maxi or big Ca 2ϩ -activated K channels (BK Ca 2ϩ) in nonrenal vessels (34, 39, 41 (34, 39, 41) . Evidence for the presence of BK Ca 2ϩ has been demonstrated by immunohistochemistry in isolated afferent arterioles (26) and physiologically in the bloodperfused juxtamedullary nephron preparation (19, 49) . In single VSMC isolated from rabbit arcuate artery, the current amplitude of BK Ca 2ϩ at positive voltages is inhibited by iberiotoxin (IBX) (37) . The vast majority of studies of nonrenal vessels suggest that cGMP and PKG facilitate activation of BK Ca 2ϩ (30, 41) . However, some have shown that 1,2,4-oxodiazolo-[4,3-a]quinoxalin-1-one (ODQ) inhibition of guanylyl cyclase fails to alter activation of BK Ca 2ϩ channels by the NO donor sodium nitroprusside (SNP), suggesting a direct effect of NO on mesenteric artery VSMC (29) . Studies of afferent arteriolar diameter utilizing the blood-perfused juxtamedullary vascular model report that stimulation of BK Ca 2ϩ with the agonist NS-1619 causes an increase in baseline diameter and inhibits the vasoconstrictor effect of angiotensin II (ANG II). On the other hand, inhibition of BK Ca 2ϩ activity with tetraethylammonium reduces lumen diameter (49) but does not alter the response to ANG II (7) . Experiments measuring changes in RBF with ANG II fail to show an effect of IBX, a specific inhibitor of BK Ca 2ϩ, but when the channel is stimulated with the BK Ca 2ϩ agonist NS-1619 the vasoconstrictor response to ANG II is diminished (26) . Thus controversy exists in defining the physiological functional role of BK Ca 2ϩ in the contractile responses in the renal microcirculation.
We designed our experiments to test the hypothesis that activation of BK Ca 2ϩ provides an important brake on depolarization-related increases in [ (38) . However, because we are studying changes in [Ca 2ϩ ] i , and not arteriolar contraction, the effect of NO on the MLC sensitivity to Ca 2ϩ is not an issue. KCl does, of course, cause plasma membrane depolarization. We chose SNP as our source of NO because SNP is degraded inside cells to yield NO, thereby avoiding problems with spontaneous degradation in stock solutions or issues of diffusion time into the cell (1, 17) . Because certain processes may contribute to or oppose the effects of the NO/cGMP/PKG system on Ca 2ϩ signaling in VSMC, we employed a variety of pharmacological inhibitors to study these pathways.
METHODS
All studies were approved by and performed in compliance with the guidelines and practices of the University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee.
Preparation of fresh afferent arterioles. We used the magnetized polystyrene microsphere-sieving technique as previously described in our laboratory (9) to isolate afferent arterioles (Ͻ20 m in diameter) from 4.5-to 5-wk-old (80 -110 g) male Sprague-Dawley rats maintained in the Chapel Hill colony. Phosphate-buffered saline (PBS) containing (in mM) 137 NaCl, 4.1 KCl, 0.66 KH 2PO4, 3.4 Na2HPO4, 2.5 NaHCO3, 1.0 MgCl2, and 5 glucose was adjusted daily to pH 7.4 at 4°C and 23°C. The vessel segments in PBS containing 0.1% bovine serum albumin (BSA) were treated with collagenase type IV (Worthington, Lakewood NJ; 374 U/mg, 4 -5 g/ml) for 18 min at 34°C. Arterioles were loaded with fura-2 AM (3 M) and 0.1% BSA for 55 min at 23°C in the dark. After arterioles were washed with PBS, the suspension was kept in Ca 2ϩ (1.1 mM)-containing buffer on ice. Measurement of cytosolic free calcium concentration. We measured [Ca 2ϩ ]i as previously described (9) . To enhance immobilization of vessels to the coverslips, we coated the glass with CellTak (BD Bioscience, Bedford, MA). Afferent arterioles were identified by their morphology and measured external diameter of 15-20 m. As well, we required visualization of microspheres in the lumen of the afferent arteriole or in the proximal branch of an interlobular artery from which it arose, to exclude the possibility that the vessel was an efferent arteriole. A segment of an afferent arteriole was centered in a small window of the optical field that was free of glomeruli or tubular fragments. There was heterogeneity of sampling sites along the vessel length.
The VSMC were excited alternately with light of 340-and 380-nm wavelength from a dual-excitation wavelength Delta-Scan equipped with dual monochronometers and a chopper [Photon Technology International (PTI), Birmingham, NJ]. After signals passed through a barrier filter (510 nm), fluorescence was detected by a photomultiplier tube. Signal intensity was acquired, stored, and processed by an IBM-compatible Pentium computer and Felix software (PTI). Background subtraction was performed in all studies. There was no interruption in the recording during the addition of reagents to the chamber. A video camera projected images of afferent arterioles onto a video monitor, permitting visualization of contraction of vessel segments.
We previously demonstrated that application of fura-2 and pharmacological agents on the abluminal side of the afferent arteriole results in no detectable contribution to the [Ca 2ϩ ]i signal from endothelial cells (EC). Bradykinin (10 Ϫ7 -10 Ϫ5 M) increases [Ca 2ϩ ]i by 10 -25 nM, which is not significantly different from baseline. N -nitro-L-arginine methyl ester (L-NAME) does not change the [Ca 2ϩ ]i response to the endothelin-B (ETB) receptor agonist sarafotoxin in our preparation (8) , to high KCl in isolated microperfused afferent arterioles (51), or to ANG II in afferent arterioles isolated with the agarose gel infusion technique (16). We do not know whether the microspheres (4.5-m diameter) in our preparation, during their passage through arterioles and ending in glomeruli, damage EC.
Reagents. Reagents were added to the bath as concentrated solutions to achieve a final desired concentration in the buffer. When vessels were pretreated with an agent, at least 2 min elapsed before addition of KCl. We purchased 8-bromo-cyclic ADPR (8-BrcADPR), IBX, SNP and L-NAME from Sigma Aldrich (St. Louis, MO), 8-bromoguanosine 3Ј,5Ј-cyclic monophosphate (8-Br-cGMP), KT-5823, and ODQ from CalBiochem (San Diego, CA), fura 2-AM from Molecular Probes (Eugene, OR), and magnetized microspheres (4.5 m) from Spherotech (Libertyville, IL).
Rationale for pharmacological agents. We used SNP to supply a fixed exogenous amount of NO. SNP is commonly used at a concentration of 100 M to generate NO in vitro (52, 55) . Measured levels of NO in EC are in the high nanomolar range (22) . The extent to which SNP liberates NO in VSMC in our preparation is unknown but likely is in the micromolar range.
IBX (100 nM) is a specific inhibitor of the BK Ca 2ϩ channel (45) . To evaluate actions of NO and the cGMP/PKG system independent of activation of BK Ca 2ϩ, we pretreated arterioles with the inhibitor.
When we wished to examine the effects of cGMP independent of those due to NO itself, we employed 8-Br-cGMP (10 M), which resists hydrolysis and is able to enter the cell (27) .
To block the activation of the cGMP/PKG system, we used two agents. KT-5823 (1 M) blocks the activation of PKG; ODQ (10 M) antagonizes soluble guanylyl cyclase. Such intervention isolates the actions of NO independent of the cGMP/PKG system.
To eliminate the possibility of a contribution of endogenous NO, we used L-NAME (10 M) to inhibit NO synthase and the formation of NO (5, 24, 36, 51) .
We previously showed that the response of afferent arterioles to KCl depends in part on endogenous cADPR and the ryanodine receptor (RyR) to amplify Ca 2ϩ -induced Ca 2ϩ release (CICR) (11). 8-Br-cADPR antagonizes the action of cADPR on the RyR (55). Because NO has been reported to inhibit ADPR cyclase in coronary VSMC, we wanted to compare the effects of inhibiting the enzyme versus blocking its product (55) .
KCl was used at a concentration of 50 mM; higher concentrations produce only modest increments in the [Ca 2ϩ ]i response. Furthermore, we are concerned that concentrations of 100 mM lower the extracellular Na ϩ concentration sufficiently to activate reverse-mode Na ϩ /Ca 2ϩ exchange. In no case did any of the aforementioned reagents, alone or in combination, cause a statistical difference in baseline values of [Ca 2ϩ ]i in afferent arterioles. Statistics. Individual arterioles were studied only once and then discarded; thus each recording originates from a separate vessel. At least six arterioles from a minimum of two rats per experiment on two different days were examined for each data set. Data are presented as means Ϯ SE (Table 1) . Group comparisons were evaluated by one-way ANOVA, with P Ͻ 0.05 considered statistically significant (GraphPad Prism Software, La Jolla, CA).
RESULTS
Measured baseline [Ca 2ϩ ] i for the entire data set was 110 Ϯ 5 nM. In no experimental subgroup was baseline [Ca 2ϩ ] i different from control baseline (109 Ϯ 2 nM) or from the grand mean.
[Ca 2ϩ ] i response to KCl. Afferent arterioles respond to KCl (50 mM) with a prompt peak increase of 151 Ϯ 3 nM followed by a sustained plateau 50 -75 s later of ⌬101 Ϯ 2 nM above baseline (n ϭ 28, Fig. 1 , Table 1 ). [Ca 2ϩ ] i responses to KCl. We showed previously (8) that bradykinin and L-NAME do not alter the [Ca 2ϩ ] i response to sarafotoxin (ET B receptor agonist) or endothelin-1 in afferent arteriolar VSMC. In the presence of L-NAME, the peak response to KCl is ⌬126 Ϯ 21 nM and the plateau is 97 Ϯ 20 nM [P not significant (NS) for both vs. control]. To further explore a possible role of endogenous NO in our afferent arterioles, we used two inhibitors of the cGMP/PKG system, ODQ and KT-5823. In the presence of KT-5823, the peak [Ca 2ϩ ] i response to KCl is ⌬105 Ϯ 10 nM and the plateau is 77 Ϯ 10 (P ϭ NS vs. control). When arterioles are pretreated with ODQ, the [Ca 2ϩ ] i response is ⌬124 Ϯ 15 nM (n ϭ 6, P Ͼ 0.5 vs. control). These results further substantiate our assumption that EC are not physiologically active (producing endogenous NO to affect Ca 2ϩ signaling) in our preparation of afferent arterioles (Fig. 1B) .
Effect of interruption of NO/cGMP system on
Inhibition of BK Ca 2ϩ and KCl responses. Because BK Ca 2ϩ are present in afferent arterioles and because activation of the channels with NO/cGMP or an increase in [Ca 2ϩ ] i should lead to hyperpolarization and a subsequent reduction in [Ca 2ϩ ] i entry, we tested the response to KCl in the presence of the specific inhibitor IBX (100 nM). IBX has no net effect on the peak or plateau [Ca 2ϩ ] i response to KCl (⌬134 Ϯ 2 and ⌬108 Ϯ 4 nM respectively; both P ϭ NS; Figs. 1B and 2B, first 2 pairs of bars). Thus, under control conditions and in the absence of exogenous NO, there is no discernible activation of the BK Ca 2ϩ to alter [Ca 2ϩ ] i responses during KCl-induced depolarization.
[Ca 2ϩ ] i responses to KCl in afferent arterioles pretreated with SNP to generate NO. As noted above, SNP has no effect on baseline [Ca 2ϩ ] i (109 Ϯ 1 control vs. 114 Ϯ 3 nM with SNP). In the presence of SNP, however, the peak [Ca 2ϩ ] i response to KCl is reduced by ϳ50% to ⌬77 Ϯ 8 nM and the plateau by ϳ40% to ⌬60 Ϯ 2 nM (both P Ͻ 0.001; Fig. 2 (Fig. 4A, Table 1 ). The data do not exclude, however, the possibility that equal and opposite mechanisms are operative, that is, a combination of pathways inhibited by and stimulated by cGMP. Values are means Ϯ SE for no. of observations in parentheses. ͓Ca 2ϩ ͔i, cytosolic calcium concentration; L-NAME, N -nitro-L-arginine methyl ester; ODQ, 1,2,4-oxodiazolo-͓4,3-a͔quinoxalin-1-one; IBX, iberiotoxin; SNP, sodium nitroprusside; 8-Br-cADPR, 8-bromo-cyclic adenosine diphosphoribose; 8-Br-cGMP, 8-bromoguanosine 3Ј,5Ј-cyclic monophosphate. *P vs. KCl: ANOVA for "peak" P Ͻ 0.001, ANOVA for "plateau" P Ͻ 0.001; †P vs. KCl ϩ SNP: ANOVA for "peak" P Ͻ 0.001, ANOVA for "plateau" P Ͻ 0.001; NS, not significant (P Ͼ 0.05).
8-Br-cGMP plus IBX.
When arterioles are treated with both 8-Br-cGMP and IBX, the peak [Ca 2ϩ ] i response to KCl is more than doubled, increasing to ⌬340 Ϯ 27 (P Ͻ 0.001 vs. 8-Br-cGMP without IBX; Fig. 4 ADPR cyclase and NO. We designed this protocol to test the action of NO, independent of activation of BK Ca 2ϩ and other downstream consequences of cGMP/PKG signaling. By pretreating afferent arterioles with both KT-5823 and IBX, we avoid these other Ca 2ϩ -related mechanisms (Fig. 5) . Under these conditions, the peak [Ca 2ϩ ] i response to KCl is ⌬75 Ϯ 3 nM (P ϭ NS vs. SNP alone, P Ͻ 0.001 vs. control). Although NO has been implicated in the activation of BK Ca 2ϩ independent of cGMP/PKG, the presence of IBX eliminates this possibility (29) . When 8-Br-cADPR is added to SNP, the peak [Ca 2ϩ ] i response to KCl is ⌬81 Ϯ 3 (P ϭ NS vs. both SNP and SNP ϩ KT-5823 ϩ IBX), demonstrating that the specific cADPR inhibitor causes no further inhibition in the presence of NO. Thus NO alone, in the absence of other downstream effects, inhibits the [Ca 2ϩ ] i response to KCl by ϳ45%, a value very similar to that of the effect of 8-Br-cADPR on KClinduced [Ca 2ϩ ] i responses in our previous studies (11) . Because inhibition of ADPR cyclase (and formation of cADPR) diminishes mobilization of Ca 2ϩ via the RyR from the sarcoplasmic reticulum, one would expect a greater effect on initial peak rather than plateau values of [Ca 2ϩ ] i . It is generally accepted that mobilization accounts for at least half of peak . P ϭ not significant (NS) vs. control for each agent, both peak and plateau. See Table 1 for P and n values.
[Ca 2ϩ ] i responses, whereas entry is largely responsible for the plateau phase. This is indeed the case for this group of experiments (Table 1) . 
DISCUSSION
We designed the present study to test the hypothesis that activation of BK Ca 2ϩ provides an important brake on increases in [Ca 2ϩ ] i in VSMC of afferent arterioles that are depolarized by high extracellular KCl. Our new data demonstrate the importance of BK Ca 2ϩ in the global [Ca 2ϩ ] i response to KCl and uncover some of the complexities of the NO/cGMP/PKG system in Ca 2ϩ signaling in this important renal resistance arteriole.
The traditional view of the role of EC-produced NO is that NO diffuses out of the EC plasma membrane through the VSMC cell membrane and into the VSMC cytosol. More recently, it has been shown that aquaporin-1 transports NO across EC and VSMC membranes, facilitating the rate of transfer compared with simple diffusion (18) . Once transported, NO may interact directly or via the cGMP/PKG signaling system with a variety of channels or enzymes, the net result of which leads to some reversal of vasoconstriction, a major fraction of which is due to a reduction in [Ca 2ϩ ] i . Key candidates for counteracting a vasoconstrictor-induced rise in [Ca 2ϩ ] i are reduced Ca 2ϩ entry secondary to activation of BK Ca 2ϩ channels and/or inhibition of voltage-gated L-type channels and diminished Ca 2ϩ mobilization caused by inhibition of ADPR cyclase. cADPR is required for optimal operation of the RyR to produce CICR. To explore the integrated effects of NO/cGMP on afferent arteriolar VSMC, we elected to use 50 mM KCl to cause membrane depolarization and to initiate Ca 2ϩ signaling cascades. By so doing, we avoid consideration of participation of IP 3 R activation, receptor-operated Ca 2ϩ mechanisms, and arachidonic acid metabolites.
In VSMC of afferent arterioles and interlobular arteries, although BK Ca 2ϩ is highly expressed, its physiological function is poorly understood (26) . Conceptually, operation of this channel should counteract an increase in [Ca 2ϩ ] i and depolarization that follows agonist stimulation and therefore could be important in the control of renal vascular tone. Although the channel is typically viewed as Ca 2ϩ dependent, it is also voltage sensitive and activated by NO/cGMP/PKG. The weight of evidence supports activation of BK Ca 2ϩ by PKG rather than NO per se (30, 34, 39, 44) . Patch clamp studies in renal artery EC show strong voltage and cGMP dependence of BK Ca 2ϩ. In the absence of exogenous cGMP or at neutral voltage, high micromolar concentrations of Ca 2ϩ are required to open the channel (4). Depolarization enhances the open probability. The resting membrane potential in rat afferent arterioles is between Ϫ40 and Ϫ65 mV, depending on the experimental preparation (25, 53) . High extracellular KCl will, of course, depolarize the membrane. Thus assessment of the role of BK Ca 2ϩ in any experimental model must take into account four variables: ] i response to KCl nearly doubled, suggesting that the cGMP/PKG system of VSMC has both stimulatory and inhibitory components to [Ca 2ϩ ] i signaling. These are surprising and novel findings. To our knowledge, there is no previously described Ca 2ϩ signaling pathway that responds to stimulation with cGMP to increase [Ca 2ϩ ] i in VSMC. Although the NO/cGMP/PKG system has been shown to activate skeletal muscle RyR1 via S-nitrosylation and cardiac RyR2 through S-nitrosoglutathione, it has no effect on caffeine stimulation of the RyR in pulmonary and aortic VSMC (21, 32, 47) . Our results with 8-Br-cGMP in the presence of IBX are in the opposite direction of the traditional view that the cGMP/PKG system causes a decrease in [Ca 2ϩ ] i . It is well accepted that L-type VGCC provide a major pathway for Ca 2ϩ entry in afferent arterioles. cGMP has been reported to inhibit L-type Ca 2ϩ channel activity in portal vein and cultured aortic VSMC (2, 40 ] i of ϳ74 nM, is activated by 3-6 M cGMP, is voltage-and time independent, is not inhibited by niflumic acid or by DIDS (Ͻ200 M), and is inhibited by 2-6 M Zn 2ϩ (28, 36) . Subsequently, electrophysiological evidence for a Cl Ca 2ϩ , cGMP has been found in a variety of vessels such as renal, cerebral, and superior mesenteric arteries and femoral and portal veins (28) . The low IC 50 for Ca 2ϩ suggests that the channel may be partially activated at rest and contribute to maintenance of membrane potential.
Our study raises the question of a possible role of Cl Ca 2ϩ , cGMP in Ca 2ϩ signaling in afferent arteriolar VSMC. Zn 2ϩ (3 M) consistently inhibits the responses to KCl in the present study (data not shown), but because Zn 2ϩ also inhibits voltage-gated L-type channels, we cannot conclude that inhibition of a Cl Ca 2ϩ , cGMP is occurring (46) . Future studies designed to explore a functional role for Cl Ca 2ϩ , cGMP in Ca 2ϩ signaling in VSMC are required.
The importance of the role of cADPR in Ca 2ϩ signaling VSMC and in endothelial cells has been summarized in a recent review (56) . A growing body of literature demonstrates a critical role for cADPR in the Ca 2ϩ response to angiotensin, endothelin, and superoxide generation (8, 10, 56) . The ADPR cyclase of VSMC differs from the cyclase of sea urchin eggs, Aplysia, and HL-60 cells by being inhibited rather than stimulated by NO and Zn 2ϩ (6, 55) . There is convincing evidence for a direct inhibitory effect of NO on ADPR cyclase activity in membrane fragments of coronary VSMC and airway smooth muscle cells (54, 55) . Because the active site of ADPR cyclase is ectocellular, NO need only exit the EC to initiate S-nitrosylation of the enzyme (23) . Independence from entry into the VSMC plasma membrane, and from a requirement for formation of cGMP, might predict early responses to inhibition by NO in vivo, but the concentration of NO needed for Snitrosylation is not yet known. A study with gaseous NO in the isolated, perfused hydronephrotic kidney shows an ODQ-insensitive component to ANG II constriction at concentrations of Ͼ1 M NO (50) . Whether this vasorelaxant effect of NO occurs because of inhibition of ADPR cyclase is not yet known. We find that the [Ca 2ϩ ] i response of afferent arterioles to KCl in combination with SNP is not different from that achieved when both KT-5823 and IBX are blocking downstream effects of cGMP and of BK Ca 2ϩ or different from the response to KCl in the presence of the cADPR inhibitor 8-Br-cADPR. Under both of these experimental conditions, it is the peak rather than the plateau response that is largely affected, suggesting an inhibition of mobilization of [Ca 2ϩ ] i from the SR. Thus our data are compatible with a direct effect of NO on ADPR cyclase activity in afferent arterioles. We previously showed (11) that the [Ca 2ϩ ] i response of afferent arterioles to KCl involves CICR and that blockade of cADPR with 8-Br-cADPR diminishes the response by ϳ45%. Further studies are needed to explore the effects of NO on the ADPR cyclase pathway in VSMC of resistance vessels. Because the VSMC cyclase differs from that of many other cell types and because at least two ADPR cyclases have been identified in mammals (CD38 and CD157), differentiation of the distribution of enzymatic subtypes in EC and VSMC presents a particular challenge.
In summary, our study of Ca 2ϩ signaling in afferent arteriolar VSMC provides new information showing that KCl-mediated increases in [Ca 2ϩ ] i , in the presence of exogenous NO or cGMP, strongly activate BK Ca 2ϩ , suggesting an important role for this channel when intact renal resistance vessels are stimulated with depolarizing agonists. Our data are also suggestive of an inhibitory role of NO on ADPR cyclase to block the formation of cADPR and its effect on the function of the RyR. A surprising finding is that a yet to be defined PKG-dependent pathway appears to be responsible for an increase in [Ca 2ϩ ] i . Future studies need to be designed to utilize physiological depolarizing and vasoconstrictor agonists such as ANG II to further investigate the role of the NO/cGMP/PKG system in arteriolar VSMC.
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